Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0000950170-24-070707

Options or other derivatives

  • Director acquired 26,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hasnain Faheem Director 2024-06-05 Grant or award · Option to purchase common stock +26,000 26,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…